ZEB2 Biomarker May Improve TNM Risk-Stratification in CRC

A study shows ZEB2 has clinical potential and may improve TNM risk-stratification and guide treatment in colorectal cancer.

Source: CancerNetwork - October 11, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news